Skip to main content
. Author manuscript; available in PMC: 2022 Jan 6.
Published in final edited form as: Annu Rev Pharmacol Toxicol. 2020 Aug 28;61:135–157. doi: 10.1146/annurev-pharmtox-031320-111453

Table 2.

Postulated mechanisms for xenobiotic-induced autoimmunity and autoimmune disease.

Type of Exposure Silica Smoking Solvents Mercurya Asbestos
Location Lung Lung Lung/Skin Lung/Skin/GI Tract Lung
Inflammatory responses IL-1α, IL-1β
Inflammasome
MyD88, IFN-γ, IL-17, type I IFN, IRF7
NETosis
IL-1β
Inflammasome
IL-6, IL-8, TNF-α
MyD88,
NETosis
ND Endosomal TLRs
IL-6, TNF-α, IFN-γ
NETosis
IL-1β
Inflammasome
Self-Protein Modifications Citrullination
Carbonylation
Citrullination
Carbonylation
Carbonylation
Nitration
Proteolysis
Carbonylation
Carbonylation
Citrullination
Tertiary Lymphoid Structure Yes Yes ND Lymphoid Accumulations Alveolitis
Autoantibodies ACPA ACPA Scl-70 Fibrillarin Mesothelial cell
MHC association ND HLA-SE HLA-DRB1 H-2s ND
Diseases SLE, SSc, RA, ANCA-related vasculitis Seropositive RA
SLE, MS
SSc Nephrotic Syndrome Rheumatological Symptoms

A comparison of the hypothesized steps leading to autoimmunity or autoimmune disease following exposure to different xenobiotics. Silica, smoking, and solvents exposures are confidently linked to various autoimmune diseases while mercury and asbestos exposures although linked to features of autoimmunity, evidence for causation of autoimmune disease is insufficient.

a

Includes information from animal studies.

ND, not determined.

HHS Vulnerability Disclosure